Home Blog Page 1991

Energy Demands Fuel Global Nuclear Revival, With 262 Small Modular Reactors to Be Deployed by 2040

LONDON, Oct. 28, 2025 /PRNewswire/ — Rapid industrial electrification, green energy imperatives, skyrocketing data center deployments, and transmission and distribution grid capacity constraints are prompting energy stakeholders to adjust the energy mix in favor of nuclear power through Small Modular Reactors (SMRs). According to a new report from global technology intelligence firm ABI Research, 262 SMRs will be deployed globally by 2040, representing an aggregated energy generation capacity of 42 gigawatts (GW). While significant momentum is not expected until 2030, strong growth is anticipated in the second half of the next decade.

“SMRs offer a wide range of benefits,” said Dominique Bonte, Vice President, End Markets and Verticals. “Their inherent upgradeability, flexibility, scalability, and rapid deployability make them suitable for a wider range of more granular, grid-based, and on-site deployment scenarios, such as data centers and industrial sites.”

SMRs provide clean, reliable, high-density, load-following energy sources within small security perimeters, reducing permitting complexity. Moreover, a new generation of SMR designs feature innovative fail-safe passive safety mechanisms and improved sustainability through nuclear waste recycling and optimized lifecycle management, both of which will be instrumental in establishing a more favorable public opinion.

The fledgling SMR ecosystem comprises both established companies such as Rolls Royce SMR and GE Vernova Hitachi Nuclear Energy, with a long tail of challengers and startups like X-energy, NuScale Power, Aalo Atomics, Holtec, Oklo, Moltex Energy, Stellaria, and Deep Atomic. It benefits from government support in countries like the United States and the United Kingdom, as well as from a healthy investment climate, with startups like NuScale Power and Oklo having gone public and players like X-energy raising private funding from investors including Amazon.

The main barriers to SMR adoption include long regulatory approval cycles for new nuclear designs, as well as lengthy site permitting and environmental impact assessments. While regulators will hold the keys to SMR success, it’s unlikely that a timely alternative capable of meeting future clean energy demands will emerge, with fusion prospects still remote. For most governments, going ahead with SMRs will be very tempting and, in some cases, even unavoidable, to prevent economic slowdowns caused by energy constraints, particularly when it concerns powering the GW datacenters of the future.

These findings are from ABI Research’s Small Modular Reactors (SMRs) – Technologies, Applications, and Forecasts application analysis report, part of the company’s Smart Energy research service, which includes research, data, and ABI Insights. 

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info

Global
Jason Scheer
Tel: +1.516.624.2558
pr@abiresearch.com

 

Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program

EPALINGES, Switzerland, Oct. 28, 2025 /PRNewswire/ — Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised its exclusive option and entered into a worldwide license agreement with Institut du Cancer de Montpellier (ICM), France, to further advance a breakthrough program in onco-metabolism.

This license agreement builds upon the exclusive collaboration and option agreement signed between Onward Therapeutics France and ICM, Inserm and Université de Montpellier in June 2021, under which the company provided research funding to support the discovery program at ICM. The successful progress achieved through this collaboration has led to the identification of  promising compounds  and the transition of the drug discovery program into Onward Therapeutics’ development pipeline. The program is currently in lead optimization, with the goal of nominating IND-enabling candidates next year.

The program, designated OT-S00X by Onward Therapeutics, is an innovative onco-metabolism project aimed at expanding therapeutic possibilities in cancer treatment. Proof-of-principle studies have demonstrated strong preclinical efficacy, and promising candidates from two distinct chemical series  have already been identified, and compounds with improved physico-chemical properties will be generated through artificial intelligence approaches.

“OT-S00X represents a breakthrough in targeting tumor onco-metabolism. Preclinical studies have shown that the efficacy of  these compounds strongly correlates with  a predictive biomarker of response across multiple tumor types, providing a clear rationale for this novel mechanism of action.” said Dr. Armand de Gramont, Chief Scientific Officer of Onward Therapeutics.”OT-S00X introduces a differentiated metabolic strategy that broadens our pipeline and primarily provides an innovative way to tackle cancer resistance,” added Dr Alain Herrera, President of Onward Therapeutics France and Chief Medical Officer of Onward Therapeutics.

“We are delighted to strengthen our collaboration with Onward Therapeutics,” said Prof. Marc Ychou, Directeur Général of ICM. “The innovative OT-S00X program, initially developed by our research teams together with Inserm and Université de Montpellier, demonstrates the potential of translational science to generate novel therapeutic strategies in oncology. It also highlights the international reach of ICM and the strength of the Montpellier MedVallée ecosystem in driving cancer innovation.”

About Onward Therapeutics 

Onward Therapeutics (www.onward-therapeutics.com) is a clinical-stage biotechnology company focused on developing innovative cancer therapies. Led by a seasoned team in translational science and drug development, the company advances promising candidates through a fast-track development model. Its portfolio includes a bispecific antibody (OT-A201) licensed from Biomunex Pharmaceuticals, alongside an equity investment; and an allogeneic NK cell therapy (OT-C001) developed via its majority-owned subsidiary, Emercell. Beyond these lead clinical assets, the company is developing two first-in-class early development programs, including a small molecule in onco-metabolism (OT-S00X) and a multi-specific antibody platform (OT-A30X). The company operates in Epalinges, Paris, and Taipei.

 About Institut du Cancer Montpellier (ICM)

Founded in 1923, ICM is one of 18 French Comprehensive Cancer Centres dedicated to patient care, research, and innovation. A member of the Unicancer group and directed by Prof. Marc Ychou, ICM combines multidisciplinary patient management with cutting-edge research spanning from basic biology to clinical applications. Its research arm, the Institut de Recherche en Cancérologie de Montpellier (IRCM), co-managed with Inserm and Université de Montpellier, brings together over 200 researchers working closely with clinicians, and is recognized by the French National Cancer Institute as an Integrated Cancer Research Center (SIRIC).

Utility and Seongnam City Sign H2Gen® Hydrogen Demonstration and Certification Project

Groundbreaking “Frontier Korea” facility to advance economic industrial decarbonization and hydrogen innovation in one of the world’s leading clean energy markets

HOUSTON and SEONGNAM, South Korea, Oct. 28, 2025 /PRNewswire/ — Utility, the global economic industrial decarbonization company headquartered in the USA, who is currently commercializing its proprietary and proven H2Gen® technology platform, today announced it has signed a Project Agreement with the Seongnam Municipal Government of Korea at Seongnam City Hall to establish an H2Gen Demonstration and Certification plant at the Seongnam Water Reclamation Center.

Utility and Seongnam City Sign H2Gen® Hydrogen Demonstration and Certification Project
Utility and Seongnam City Sign H2Gen® Hydrogen Demonstration and Certification Project

Seongnam has long been a leader and innovator in circular economy and clean energy initiatives such as hydrogen. Seongnam will host the Project, known as the “Frontier Korea” facility, which is the first of its kind outside of the US.

The agreement represents a strategic initiative to support South Korea’s Hydrogen Economy Roadmap which prioritizes biogas and hydrogen as energy sources to achieve carbon neutrality and reduce reliance on imported fossil fuels. The country is investing heavily in biogas projects, converting organic waste into clean energy to reduce greenhouse gas emissions and enhance waste management.

Frontier Korea will see Utility build and operate a clean-carbon hydrogen production plant producing over 99.995% pure hydrogen (fuel-cell grade) and deliver hydrogen to the E1 hydrogen refueling station in Seongnam for use in fuel-cell buses, trucks, and cars. Korea has one of the most developed hydrogen-powered vehicle markets in the world, which Utility believes holds significant potential for its H2Gen technology. Through H2Gen, Utility electrochemically produces hydrogen from water without electricity, utilizing raw biogas energy from the anaerobic digestion of organic waste.

This Project will also verify H2Gen® hydrogen production technology in Korea by meeting Korea Gas Safety standards, paving the path for rapid expansion in Korea across multiple industry sectors. Korea is one of Utility’s key focus markets given the significant opportunities in the nation across biogas, steel, refining and chemicals, all target markets for Utility’s H2Gen technology. Utility also recently established a fully-owned subsidiary in Seongnam, Utility Korea LLC, and made a qualifying investment under the Foreign Investment Promotion Act (FIPA).

“This project marks an innovative step beyond the traditional role of wastewater treatment, establishing a foundation for clean energy,” adding, “It is expected to advance carbon neutrality, resource circulation, clean energy infrastructure, and international cooperation — thereby enhancing Seongnam City’s ESG values,” stated Lim Jong-cheol, Deputy Mayor of Seongnam Municipal Government. “Our collaboration with Utility represents a continued commitment towards these important objectives.”

On October 10, Utility started operations on its US-based Frontier Facility in Houston, Texas, where long duration runtimes with various feed gases and 24/7 operations will continue to show H2Gen®‘s versatility and wide applicability in economic industrial decarbonization. The Frontier Korea facility will be a near replica of this proven modular plant.

“Korea, a demonstrated leader in decarbonization, is a strategic priority for our company,” stated Parker Meeks, Chief Executive Officer and President of Utility. “We applaud the Seongnam Municipal Government, for its decision to join us on this important project, to enable our H2Gen® technology’s ability to deliver game-changing economic decarbonization in multiple industrial sectors in Korea, starting with heavy mobility.”

About Utility Global

Utility delivers practical solutions that drive economic industrial decarbonization across industries such as steel, mobility, refining, chemicals, and upstream oil & gas. The company’s breakthrough H2Gen® technology harnesses energy from industrial off-gases and biogases to produce application-specific high-purity, low-to-negative carbon intensity hydrogen on-site from water, without electricity, using its proprietary electrochemical process. H2Gen also produces a high-concentration carbon dioxide stream, which can eliminate or reduce the cost of carbon capture. H2Gen systems are modular, scalable, and operationally flexible, integrating seamlessly into existing hard-to-abate industrial assets with a record small footprint, enabling practical, economic decarbonization.

Utility is a portfolio company of Ara Partners, a global private equity and infrastructure firm that is decarbonizing the industrial economy.” For more information, visit www.utilityglobal.com.

About Ara Partners

Ara Partners is a global private equity and infrastructure investment firm focused on industrial decarbonization. Founded in 2017, Ara Partners seeks to build and scale companies with significant decarbonization impact across the industrial and manufacturing, chemicals and materials, energy efficiency and green fuels, and food and agriculture sectors. The company operates from offices in Houston, Boston, Washington D.C., and Dublin. Ara Partners closed its third private equity fund in December 2023 with over $2.8 billion in capital commitments. As of June 30, 2025, Ara Partners had approximately $6.6 billion of assets under management.

For more information about Ara Partners, please visit www.arapartners.com.

Photo – https://laotiantimes.com/wp-content/uploads/2025/10/utility_seongnam.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2025/10/utility_global_2025_logo-1.jpg

Acclime Acquires Crowe Singapore to Create Regional Professional Services Powerhouse

SINGAPORE, Oct. 28, 2025 /PRNewswire/ — Acclime, a leading corporate services and advisory firm, today announced the acquisition of Crowe Singapore, one of Singapore’s top accounting and advisory practices. The combination marks a significant milestone in Acclime’s growth journey and reinforces its evolution to a full-service regional firm serving clients across Asia Pacific and the Middle East. With this acquisition, Acclime will become one of the largest professional services firms in Singapore.

Crowe Singapore brings deep local expertise in assurance, tax, and advisory together with Acclime’s regional leadership in corporate governance, compliance, accounting, and fund administration. With one unified offering, the combined organisation will serve a diverse and growing range of local clients, regional enterprises, multinationals, funds, and family offices with consistent service standards and coordinated expertise across all markets.

“This acquisition transforms our scale, capability, and client value proposition,” said Izzy Silva, Group CEO of Acclime. “Crowe Singapore is one of the most trusted names in the market, and together we’ve created a platform that fundamentally elevates what clients can expect from a regional partner: technical excellence, institutional-grade fund administration, and integrated solutions that work across borders. Our teams operate as one firm, ensuring that expertise and insights flow freely to benefit every client, wherever they operate.”

“Joining Acclime allows us to bring our clients into a broader ecosystem of expertise and innovation,” said Tan Kuang Hui, Managing Partner of Crowe Singapore. “We share a strong commitment to quality and client partnership and now have the scale and reach to deliver enhanced value both locally and regionally.”

This acquisition represents the latest in Acclime’s strategic shift toward high-value advisory services and fund administration. In recent years, Acclime has strengthened its advisory capabilities through targeted acquisitions of some of the top regional firms in Hong Kong SAR, Australia, and in New Zealand. Each acquisition has added specialized expertise, enabling Acclime to deliver sophisticated advisory solutions alongside its strong corporate services and accounting core. The addition of Crowe Singapore reflects Acclime’s continued commitment to building a firm that delivers exceptional service through enhanced on-the-ground market knowledge, regional coordination and international reach.

About Crowe Singapore

Crowe Singapore is an award-winning firm that leverages its core strengths in audit, advisory, tax, risk consulting, corporate services, outsourcing, fund administration and valuation to bring smart decisions that create lasting value for its clients. With a global reach, and a local expertise, Crowe Singapore is well positioned as a one-stop, integrated solutions provider of a full suite of professional services to a diverse and international clientele, including public-listed entities, multinational corporations, and financial institutions.

About Acclime

Acclime is a leading professional services firm providing integrated corporate services, fund administration, accounting, tax, and advisory solutions across Asia Pacific and the Middle East. With over 2,000 professionals operating as one unified firm across 18 markets, Acclime serves a diverse range of private clients, regional enterprises, multinationals, funds, and family offices. The firm combines deep market knowledge, cross-border expertise and industry leading tech-enablement to help clients navigate complex regulatory environments, scale their operations and achieve their strategic objectives at every stage of success.

Nippon Shinyaku Selects LifeSphere® Safety

Japan-based Nippon Shinyaku has chosen LifeSphere MultiVigilance as new case processing database

TOKYO, Oct. 28, 2025 /PRNewswire/ — ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®, today announced that Nippon Shinyaku, Ltd. has selected its LifeSphere® Safety platform.

Nippon Shinyaku sought a global single database and streamlined workflow to unify its domestic and international safety processes. The company selected LifeSphere® for its proven automation capabilities, successful track record of implementations and change management in Japan and worldwide, and ability to support both global and local compliance requirements.

The LifeSphere Safety selection includes:

  • LifeSphere® MultiVigilance – an end-to-end case processing and safety data management, designed to scale globally.
  • LifeSphere® Business Intelligence – a powerful analytics and reporting solution that delivers real-time insights into safety operations, enabling data-driven decision-making, compliance tracking, and operational optimization.
  • LifeSphere® Reporter – a multilingual field reporting solution that streamlines adverse event intake from sales representatives and affiliates, supporting real-time global capture of critical safety data.

“We are pleased to begin our collaboration with ArisGlobal by adopting LifeSphere Safety,” said Ms. Hitomi Kimura, Director, Resource Procurement, Production & Assurance, Nippon Shinyaku. “This transition will allow us to increase efficiency, reduce external costs, and gain clearer visibility into global safety data, all while ensuring compliance across our operations.”

“Nippon Shinyaku’s move to LifeSphere reflects a growing demand from Japanese and global life sciences organizations for platforms that deliver efficiency today while creating a strong foundation for future innovation,” said Zhiyi Chen, Senior Vice President, APAC, ArisGlobal. “We are proud to partner with Nippon Shinyaku and applaud their commitment to building a forward-looking Safety function.”

This new customer builds on ArisGlobal’s recent momentum across the Asia-Pacific region, where the company recorded a 233% year-over-year increase in LifeSphere implementations.

About ArisGlobal 

ArisGlobal, an AI-first technology company and creator of LifeSphere®, is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com.

About Nippon Shinyaku 

Based on Nippon Shinyaku’s business philosophy, “Helping people lead healthier, happier lives,” we aim to be an organization trusted by the community through creating unique medicines that will bring hope to patients and families suffering from illness. Please visit our website (https://www.nippon-shinyaku.co.jp/english/) for products or detailed information.

Meet HI the AI Assistant That Could Change How Finance Thinks, Decides and Leads

SYDNEY, Oct. 28, 2025 /PRNewswire/ — In the high-pressure world of modern finance, decisions are made in seconds – but their impact can last a lifetime. For over 30 years, The Ethics Centre, an independent not-for-profit, has supported individuals and organisations in making ethical decisions they can stand by. Now, in partnership with Miroma Project Factory (MPF), it has developed HI (Human Intelligence): a groundbreaking AI prototype that is designed to bring ethical reflection into the everyday workflow of banking and finance professionals.

HI AI ethics assistant developed by The Ethics Centre and MPF to support ethical choices in finance and banking.
HI AI ethics assistant developed by The Ethics Centre and MPF to support ethical choices in finance and banking.

HI AI ethics assistant developed by The Ethics Centre and MPF to support ethical choices in finance and banking.
HI AI ethics assistant developed by The Ethics Centre and MPF to support ethical choices in finance and banking.

In a world increasingly shaped by artificial intelligence, powered by natural language processing and guided by deep sector insight, HI offers a different vision: instead of using AI to make decisions for people, the project explores how to use it to deepen what makes us human. Rather than outsourcing our thinking or faster answers; it focuses on better questions. HI recognises that our values, empathy, and gut instincts are vital strengths; and enhances them.

The demand for a tool like this is clear, especially for younger professionals in the finance sector. According to Deloitte’s 2024 Gen Z and Millennial Survey, half of Gen Zs (50%) and 43% of millennials have rejected an assignment or project based on personal ethics or beliefs, and almost as many have walked away from employers altogether. Meanwhile, 77% of frontline finance staff say they face ethical decisions multiple times a day, yet few feel they have the time, or the tools, to navigate those dilemmas well.

Each year, The Ethics Centre mentors early career professionals through its Banking and Financial Services Oath (BFSO) Young Ambassador Program. The Centre works with them to develop projects that increase ethical knowledge and skills in that industry – especially amongst young people. HI was a project that the Young Ambassadors helped develop as an example of how AI could be used to embed ethical decision making in daily decisions at work.

Cris Parker, Director of BFSO at The Ethics Centre said: “As new technologies like AI emerge, it’s common to hear a wide range of predictions – some hopeful, others more cautious. The Ethics Centre is collaborating with organisations like CSIRO to help establish clear and responsible ethical guidelines for how this powerful and transformative technology is developed and used. HI is one example of a prototype designed to support thoughtful, informed decision-making both now and in the future. It shows how technology can be applied in a practical, meaningful way to address real-world challenges with care and insight.”

The HI MVP has been designed to be delivered as a browser-based widget and Slack/Teams plugin, designed to meet people where they already are. Feedback from the Young Ambassadors expressed a need for tools for self-reflection and guidance to help think through difficult professional challenges.  Whether a user is working through a tough customer decision, questioning a workplace policy, or just needs a moment of self-reflection, HI provides real-time, context-aware prompts that guide ethical thinking, not prescribe it.

“For today’s workforce, ethics is not theoretical. It’s personal,” said Kat Robinson, Global CEO of MPF

“This generation doesn’t just want to do good work – they want to do work that is good. Projects like HI are our answer to that challenge: a quiet, consistent companion that helps people think clearly, act thoughtfully, and lead with integrity in the flow of their day.  HI shows that AI doesn’t have to replace judgment; it can restore it. We’re showing that we can use technology not to make decisions for people, but to make people better at making decisions. And that’s what the future of work demands,” said Robinson.

Early beta user testing has confirmed its value:

  • 95% said the tool helped them understand how their values influence their decisions
  • 82% believe a tool like this would be helpful industry-wide
  • 91% rated the tool’s dashboard and feedback features positively

HI is being designed to be more than a reflection prompt. It aims to be a sophisticated learning ecosystem combining interactive ethical scenarios, micro-lessons, decision-tree guidance, and streak-based gamification to promote ongoing engagement and skill-building. Using fiction and storytelling, the tool invites users to explore difficult scenarios with emotional and cognitive safety. Over time, it is designed to build people’s ethical muscle.

While it is currently still in its R&D phase, the tool’s ultimate goal is to make ethical consideration consistent, woven into the rhythm of daily work, not reserved for workshops or crisis meetings. For financial services in particular, where even minor decisions can have major consequences, a shift like this could redefine trust, integrity, and accountability at scale.

About The Ethics Centre:
The Ethics Centre is an independent not-for-profit organisation that brings ethics to the centre of everyday life. Through consulting, advice, education and public engagement, the Centre helps individuals and organisations navigate moral complexity with confidence and integrity. Learn more at www.ethics.org.au.

About Miroma Project Factory (MPF)
MPF is a multi-award-winning digital strategy and product studio that delivers innovative digital solutions across web, platforms, and systems. Specialising in purposeful technology, MPF works at the intersection of strategy, design, and engineering to create impactful digital products for organisations ready to lead. With deep expertise in healthcare, MPF helps clients scale responsibly, communicate clearly, and connect meaningfully with their audiences. For more information, visit www.theprojectfactory.com.

For media enquiries, interviews or partnership opportunities, please contact:
Miroma Project Factory
info@theprojectfactory.com 

The Ethics Centre
communications@ethics.org.au 

Greenhouse Reinforces Commitment to Australian Customers with Real Talent Launch and New SEEK Integrations

NEW YORK, Oct. 28, 2025 /PRNewswire/ — Today, leading hiring platform Greenhouse shares additional business momentum in the Australian market to help customers gain more confidence in their hiring processes, from sourcing to offer to onboarding. The company recently surpassed 9M job applications across its customers in the Asia Pacific region, and will continue to deepen its product innovation to offer candidates and hiring managers in Australia a more human way of hiring, including advanced SEEK integrations and the launch of Greenhouse Real Talent.

Greenhouse’s new SEEK integrations include “Apply with SEEK,” which improves the candidate experience by allowing job seekers to easily apply to roles using their SEEK profile and “Ad Sync,” which enables employers to advertise on a leading Asia Pacific job board without any ongoing effort from their hiring team. Each new integration is slated to release by the end of Q4 2025. Greenhouse Real Talent, which helps businesses identify the most relevant applicants, and fight spam and fraud during the talent acquisition process, will become available in early 2026. Together, these solutions make the hiring process more than a numbers game for employers and job seekers in Australia.

“We now proudly partner with more than 200 customers in the Asia-Pacific region – high-growth Australian brands and local businesses alike – to help them become better at hiring. Our presence in Australia showcases our commitment and the value we bring to hiring, one of the most strategic function areas of any business. Any business absolutely must have the right talent to achieve its goals and remain competitive in the Australian market right now,” said Daniel Chait, CEO and co-founder of Greenhouse.

Greenhouse is a proud sponsor of this year’s ATC conference in Melbourne, Australia. Join Daniel Chait, along with Jodette Cleary, Chief People and Culture Officer at Hipages, as they discuss “Future-forward hiring and the impact of AI on the main stage at 12:10pm AEDT. Daniel and Jodette will cover topics about how to navigate and overcome the AI “doom loop,” practical ways to make hiring easier and more efficient, and how to embrace the benefits AI will bring to both hiring managers and candidates alike.

About Greenhouse
Greenhouse is the leading hiring platform to help companies get measurably better at hiring.

With Greenhouse, organizations can ensure every hire is the right hire, taking candidates from talented prospects to top performers. Our industry-leading software brings a structured hiring approach to any company’s process, helping to define the role, requirements and attributes a successful candidate should have before a job is posted, enabling internal alignment and confident decision-making. The result is more fair and equitable hiring practices combined with data-driven decisions.

We’ve helped over 7,500 companies across diverse industry verticals and scaling goals turn talent into a strategic advantage, so they can be ready to hire for what’s next. Some of the smartest and most successful companies like HubSpot, Duolingo, Gong, J.D. Power and Scout24 use Greenhouse for data and guidance on the behaviors and capabilities they need to improve their overall hiring performance as they move up the Hiring Maturity curve.

Greenhouse has won numerous awards including TIME Best Inventions 2025, Fortune Best Workplaces, Inc. Magazine Best Workplace, Glassdoor #1 Best Place to Work, Forbes Cloud 100, Deloitte Technology Fast 500, Inc. 5000, Crain’s Best Places to Work NYC and Mogul’s Top 100 Workplaces for Diverse Representation.

© 2025, Greenhouse Software, Inc. All rights reserved. Greenhouse, the G Logo, “Hire for what’s next,” “The/Your all-together hiring platform,” “Talent Makers,” “Real Talent” and “Strong Yes” are among the trademarks of Greenhouse Software, Inc.

Logo – https://laotiantimes.com/wp-content/uploads/2025/10/greenhouse_wordmark_green_logo.jpg

PARTNERSHIP ANNUAL DINNER TO BRING THE ENERGY WITH BESTSELLING AUTHOR

GREATER DES MOINES, Iowa, Oct. 28, 2025 /PRNewswire/ — The Greater Des Moines Partnership has announced that bestselling author and acclaimed speaker Jon Gordon will be the keynote speaker at its 2026 Annual Dinner, set for Thursday, Jan. 22, 2026, at the Community Choice Credit Union Convention Center in Downtown Des Moines.

The evening will include a reception beginning at 5 p.m. followed by the keynote and dinner at 6:30 p.m. The program will feature the presentation of The Partnership’s Annual Report, updates on key initiatives and a keynote address from Gordon.

Gordon’s books and talks have inspired millions worldwide, with principles embraced by Fortune 500 companies, professional and collegiate sports teams, school districts and nonprofits. He is the author of 32 books, including 18 bestsellers such as “The Energy Bus,” “The Carpenter,” “The Power of Positive Leadership,” “The One Truth” and his latest release “The 7 Commitments of a Great Team.” His work has been featured on “The Today Show,” CNN, CNBC, “Fox and Friends” and in numerous national publications.

“The Annual Dinner celebrates not just accomplishments, but the spirit of collaboration that fuels everything we do in Greater Des Moines,” said Miriam Erickson Brown, Chair and CEO of Anderson Erickson Dairy and 2025 Board Chair of The Partnership. “Jon’s insights on positive leadership and teamwork couldn’t come at a better time as we look to the year ahead.”

The Annual Dinner serves as the region’s premier business event, bringing together hundreds of leaders from across Greater Des Moines to celebrate the past year’s economic and community development successes and to preview the organization’s strategic priorities for the year ahead.

Through this marquee event, The Partnership also supports local businesses by sourcing desserts, speaker gifts and musical and cultural entertainment from Greater Des Moines vendors, reinforcing the organization’s commitment to local economic impact.

Reservations are accepted online at The Partnership’s website. Space is limited, and attendees are encouraged to secure their seats early. For Partnership Investors, premier seating tables are $2,200, general seating tables are $1,800 and individual tickets are $225 per person. For non-Investors, tables are $2,400 and individual tickets are $300. Advanced pricing is available through Jan. 8. Beginning Jan. 9, pricing will increase by $200 per table and $25 per individual ticket. Each table seats eight and refunds will not be issued after Jan. 15.

For more information about the 2026 Annual Dinner featuring Jon Gordon, contact Amelia Klatt, Director of Events.

About the Greater Des Moines Partnership
The Greater Des Moines Partnership is the economic and community development organization that serves 12 counties in Greater Des Moines (DSM), Iowa: Adair, Clarke, Dallas, Guthrie, Jasper, Madison, Mahaska, Marion, Marshall, Polk, Poweshiek and Warren. Together with more than 400 Investors and an Affiliate Chamber of Commerce network of more than 7,200 Regional Business Members, The Partnership drives economic growth and talent development to advance quality of life in DSM with one voice, one mission and as one region. Through innovation, strategic planning and global collaboration, The Partnership grows opportunity, helps create jobs and promotes DSM as the best place to build a business, a career and a future. Learn more at DSMpartnership.com.

Contact:
Metinka Slater
mslater@DSMpartnership.com
(515) 216-3989
Learn More About DSM USA